BGT Awarded U.S. Department of Defense Grants
Filed with ASX · · 4 pages · English
Summary by 6ix AI
The first grant will support the development of a wearable product containing Flavocide® for mosquito control, while the second grant focuses on a sprayable formulation of Qcide® for bed bug and fly infestations. These grants validate Bio-Gene's technology and aim to enhance pest control solutions for both military and civilian markets.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Bio-Gene Technology Ltd. on 6ix
Earlier from Bio-Gene Technology
- CEO's Address to Shareholders
- Bio-Gene Receives $535000 R&D Tax Incentive
- BGT Investor Presentation Oct24
- Investor Webinar Presentation 06 Sep 24
- Bio-Gene & Rallis achieve key Flavocide production milestone
Later from Bio-Gene Technology
- BGT Investor Webinar 4-Feb-25 Slides
- Appendix 4D and Half-Year Accounts 31 December 2024
- Bio-Gene Presentation - NWR Virtual Healthcare Conference
- Trading Halt
- Result of Placement
Follow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology